Table 1.
Characteristic | |
---|---|
Age mean ± SD years | 56 ± 12 |
Gender (%) | |
Male | 56 (67) |
Female | 28 (33) |
Primary Disorder (%) | |
Acute myeloid leukemia | 33 (39) |
Acute lymphoid leukemia | 6 (7) |
Chronic myeloid leukemia | 5 (6) |
Chronic lymphoid leukemia | 10 (12) |
Myelodysplastic syndrome | 11 (13) |
Non-Hodgkin Lymphoma | 13 (16) |
Hodgkin Lymphoma | 1 (1) |
Multiple myeloma | 3 (4) |
Others | 2 (2) |
Duration since HSCT in days mean ± SD | 1348 ± 1002 |
Duration since diagnosis of ocular GVHD in days mean ± SD | 873 ± 955 |
SD: standard deviation; HSCT: hematopoietic stem cell transplantation; GVHD: graft-versus-host disease.